...
首页> 外文期刊>Cardiovascular & hematological disorders drug targets >Reduction of myocardial ischemia-reperfusion injury with pre- and postconditioning: molecular mechanisms and therapeutic targets.
【24h】

Reduction of myocardial ischemia-reperfusion injury with pre- and postconditioning: molecular mechanisms and therapeutic targets.

机译:通过预处理和后处理减少心肌缺血/再灌注损伤:分子机制和治疗目标。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Reduction of infarct size as well as alleviation of other ischemia- and reperfusion-associated injuries are the goals of primary importance in cardiology. One of the remedies is considered to be myocardial preconditioning (PreCon) referred usually to as an increased myocardial tolerance to prolonged ischemia following brief ischemic or non-ischemic challenge. In this review, PreCon stimuli tested to date are considered including a number of mildly noxious factors applied either locally to the myocardium or systemically. Recently, one more mode of heart protection against reperfusion injury termed postconditioning (PostCon) has been developed. On the basis of ample evidence published, along with our findings, a detailed comparative analysis of PreCon and PostCon is presented, with special emphasis on the cellular, molecular, and pharmacological aspects of the topic as well as clinical applications, both implemented and awaiting practical approval.
机译:减少梗塞面积以及减轻其他与缺血和再灌注相关的损伤是心脏病学的首要目标。补救措施之一被认为是心肌预处理(PreCon),通常指短暂的缺血或非缺血发作后,其对长时间缺血的心肌耐受性增加。在这篇综述中,考虑到迄今为止已测试的PreCon刺激物,包括许多局部应用到心肌或全身应用的轻度有害因子。最近,已经开发了另一种称为再适应(PostCon)的防止再灌注损伤的心脏保护模式。根据已发表的大量证据以及我们的发现,对PreCon和PostCon进行了详细的比较分析,特别强调了该主题的细胞,分子和药理学方面以及临床应用,已实施并有待于实践。批准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号